Clinical Trial Update: Efficacy and Safety of Two Dry Power Inhalers (DPIs) Used for the Application of Mometasone in the Treatment of Asthma [Phase 3]

View source ↗

Summary

A Phase 3 study evaluated the efficacy and safety of two dry powder inhalers delivering mometasone furoate for asthma; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Mometasone furoate (Mometasone furoate)

Snippet

Sponsor: Mantecorp Industria Quimica e Farmaceutica Ltd. | Conditions: Asthma | Phase 3 | Status: COMPLETED